Acquired FXIII Deficiency is Associated with High Morbidity

Patricia Duque; Maite Chasco-Ganuza; Ariana Ortuzar; Carolina Almaraz; Estrella Terradillos; Gloria Perez-Rus; Cristina Pascual

doi:10.1055/a-1481-2733

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2022; 122(01): 048-056
DOI: 10.1055/a-1481-2733

Coagulation and Fibrinolysis

Acquired FXIII Deficiency is Associated with High Morbidity

Patricia Duque

¹Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain

²Gregorio Marañon Health Research Institute, Gregorio Marañon Hospital, Madrid, Spain

,

Maite Chasco-Ganuza

¹Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain

,

Ariana Ortuzar

³Department of Hematology, Gregorio Marañon Hospital, Madrid, Spain

,

Carolina Almaraz

¹Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain

,

Estrella Terradillos

¹Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain

,

Gloria Perez-Rus

³Department of Hematology, Gregorio Marañon Hospital, Madrid, Spain

⁴Internal Medicine Department, Complutense University, Madrid, Spain

,

Cristina Pascual

³Department of Hematology, Gregorio Marañon Hospital, Madrid, Spain

²Gregorio Marañon Health Research Institute, Gregorio Marañon Hospital, Madrid, Spain

› Institutsangaben

Abstract

Background A factor XIII (FXIII) level >30% is considered necessary to prevent spontaneous bleeding. Bleeding is also a risk in patients with acquired FXIII deficiency, but the hemostatic level of FXIII in this context remains to be determined.

Methods We retrospectively analyzed all patients diagnosed with acquired FXIII deficiency at a large hospital over 3 years (study ID NCT04416594, http://www.clinicaltrials.gov) and assessed clinical data to identify the best cut-off point for FXIII activity to distinguish between low and high risk of major bleeding in a mixed medical and surgical population.

Results Of the 97 patients who experienced bleeding despite a normal coagulation test, 43.2% had FXIII activity <70%. FXIII activity was significantly lower in surgical patients and patients admitted to the intensive care unit (ICU). Low FXIII activity was significantly associated with long ICU stays and a high incidence of major bleeding.

Conclusion Acquired FXIII deficiency is associated with high morbidity. The hemostatic level of FXIII in the setting of acquired FXIII deficiency might be above 30%.

Keywords

FXIII deficiency - hemorrhage - morbidity - blood transfusion - postoperative

Volltext

Referenzen

References
1 Levy JH, Greenberg C. Biology of factor XIII and clinical manifestations of Factor XIII deficiency. Transfusion 2013; 53 (05) 1120-1131
2 Mannucci PM, Duga S, Peyvandi F. Recessively inherited coagulation disorders. Blood 2004; 104 (05) 1243-1252
3 Peyvandi F, Palla R, Menegatti M. et al; European Network of Rare Bleeding Disorders Group. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10 (04) 615-621
4 Yan MTS, Rydz N, Goodyear D, Sholzberg M. Acquired factor XIII deficiency: a review. Transfus Apheresis Sci 2018; 57 (06) 724-730
5 Schroeder V, Kohler HP. Factor XIII deficiency: an update. Semin Thromb Hemost 2013; 39 (06) 632-641
6 Gando S, Kamiya K, Makise H, Tedo I, Nakanishi Y. Wound healing, blood coagulation and fibrinolysis during operations involving gastric cancer surgery [in Japanese]. Nippon Geka Gakkai Zasshi 1989; 90 (01) 59-63
7 Gerlach R, Tölle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33 (06) 1618-1623
8 Gödje O, Gallmeier U, Schelian M, Grünewald M, Mair H. Coagulation factor XIII reduces postoperative bleeding after coronary surgery with extracorporeal circulation. Thorac Cardiovasc Surg 2006; 54 (01) 26-33
9 Kanda A, Kaneko K, Obayashi O, Mogami A, Presentation C. The massive bleeding after the operation of hip joint surgery with the acquired haemorrhagic coagulation factor XIII(13) deficiency: two case reports. Case Rep Orthop 2013; 2013: 473014
10 Watanabe N, Yokoyama Y, Ebata T. et al. Clinical influence of preoperative factor XIII activity in patients undergoing pancreatoduodenectomy. HPB (Oxford) 2017; 19 (11) 972-977
11 Blome M, Isgro F, Kiessling AH. et al. Relationship between factor XIII activity, fibrinogen, haemostasis screening tests and postoperative bleeding in cardiopulmonary bypass surgery. Thromb Haemost 2005; 93 (06) 1101-1107
12 Adelmann D, Klaus DA, Illievich UM. et al. Fibrinogen but not factor XIII deficiency is associated with bleeding after craniotomy. Br J Anaesth 2014; 113 (04) 628-633
13 Kohler HP, Ichinose A, Seitz R, Ariens RAS, Muszbek L. Factor XIII And Fibrinogen SSC Subcommittee Of The ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 9 (07) 1404-1406
14 Marshall JC. The multiple organ dysfunction syndrome. In: Surgical Treatment, Evidence-Based and Problem-Oriented. Holzheimer RG, Mannick JA. eds. Munich: Zuckschwerdt; 2001
15 Haas T, Korte W, Spielmann N. et al. Perioperative course of FXIII in children undergoing major surgery. Paediatr Anaesth 2012; 22 (07) 641-646
16 Kozek-Langenecker SA, Ahmed AB, Afshari A. et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology: first update 2016. Eur J Anaesthesiol 2017; 34 (06) 332-395
17 von Rappard S, Hinnen C, Lussmann R, Rechsteiner M, Korte W. Factor XIII deficiency and thrombocytopenia are frequent modulators of postoperative clot firmness in a surgical intensive care unit. Transfus Med Hemother 2017; 44 (02) 85-92
18 Theusinger OM, Baulig W, Asmis LM, Seifert B, Spahn DR. In vitro factor XIII supplementation increases clot firmness in rotation thromboelastometry (ROTEM). Thromb Haemost 2010; 104 (02) 385-391
19 Tone KJ, James TE, Fergusson DA. et al. Acquired factor XIII inhibitor in hospitalized and perioperative patients: a systematic review of case reports and case series. Transfus Med Rev 2016; 30 (03) 123-131
20 Korte WC, Szadkowski C, Gähler A. et al. Factor XIII substitution in surgical cancer patients at high risk for intraoperative bleeding. Anesthesiology 2009; 110 (02) 239-245
21 Schulman S, Kearon C. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost 2005; 3 (04) 692-694
22 Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W. Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010; 8 (01) 202-204
23 Chang S-H, Chou I-J, Yeh Y-H. et al. Association between use of non-vitamin K oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation. JAMA 2017; 318 (13) 1250-1259
24 Spahn DR, Bouillon B, Cerny V. et al. The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition. Crit Care 2019; 23 (01) 98
25 Lawrie AS, Green L, Mackie IJ, Liesner R, Machin SJ, Peyvandi F. Factor XIII--an under diagnosed deficiency--are we using the right assays?. J Thromb Haemost 2010; 8 (11) 2478-2482
26 Nielsen VG. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand 2005; 49 (08) 1163-1171
27 Raspé C, Besch M, Charitos EI. et al. Rotational thromboelastometry for assessing bleeding complications and factor XIII deficiency in cardiac surgery patients. Clin Appl Thromb Hemost 2018; 24 (9_suppl): 136S-144S
28 Weber CF, Sanders JO, Friedrich K. et al. Role of thrombelastometry for the monitoring of factor XIII. A prospective observational study in neurosurgical patients [in German]. Hamostaseologie 2011; 31 (02) 111-117